Heterogeneity in Multiple Sclerosis: Scratching the Surface of a Complex Disease
Multiple Sclerosis (MS) is the most common demyelinating disease of the central nervous system. Although the etiology and the pathogenesis of MS has been extensively investigated, no single pathway, reliable biomarker, diagnostic test, or specific treatment have yet been identified for all MS patients.
Giulio Disanto +9 more
wiley +1 more source
Obsessive–Compulsive Symptoms in Neurologic Disease: A Review
Obsessive–compulsive disorder (OCD) is an increasingly recognized disorder with a prevalence of 2–3% (Robins et al., 1984). Once thought to be psychodynamic in origin, OCD is now generally recognized as having a neurobiological cause. Although the exact pathophysiology of OCD in its pure form remains unknown, there are numerous reports of obsessive ...
M. S. George +2 more
wiley +1 more source
Neuroimaging Scoring Tools to Differentiate Inflammatory Central Nervous System Small-Vessel Vasculitis: A Need for Artificial Intelligence/Machine Learning?-A Scoping Review. [PDF]
Damer A +6 more
europepmc +1 more source
Baló's concentric sclerosis presenting asymptomatically in a child: clinico-radiological-pathological correlation. [PDF]
Southin JC +4 more
europepmc +1 more source
A rare presentation of multiple sclerosis: Schilder's disease. [PDF]
Taoussi R +7 more
europepmc +1 more source
Pediatric tumefactive multiple sclerosis case (with baló-like lesions), diagnostic and treatment challenges. [PDF]
Kamari C +5 more
europepmc +1 more source
A historical look using virtual microscopy: the first case report of adrenomyeloneuropathy (AMN). [PDF]
Budka H.
europepmc +1 more source
Endocrine dysfunction in adrenoleukodystrophy. [PDF]
Engelen M, Kemp S, Eichler F.
europepmc +1 more source
Clinical and Radiologic Features, Pathology, and Treatment of Baló Concentric Sclerosis. [PDF]
Jolliffe EA +6 more
europepmc +1 more source
Delineating selective vulnerability of inhibitory interneurons in Alpers' syndrome. [PDF]
Smith LA +5 more
europepmc +1 more source

